Sept. 8, 2004 — The U.S. Food and Drug Administration (FDA) approved in June revisions to safety labeling to advise healthcare professionals of the following changes: estradiol/norethindrone patches ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback